Bill Sponsor
House Bill 5663
116th Congress(2019-2020)
Safeguarding Therapeutics Act
Became Law
Amendments
Became Law
Became Public Law 116-304 on Jan 5, 2021
Overview
Text
Introduced
Jan 21, 2020
Latest Action
Jan 5, 2021
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
5663
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
House Votes (1)
Senate Votes (1)
checkPassed on September 21, 2020
Status
Passed
Type
Voice Vote
Voice Vote
A vote in which the presiding officer states the question, then asks those in favor and against to say "Yea" or "Nay," respectively, and announces the result according to his or her judgment. The names or numbers of senators voting on each side are not recorded.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
Summary

Safeguarding Therapeutics Act

This bill authorizes the Food and Drug Administration to destroy imported counterfeit medical devices.

Text (6)
September 22, 2020
September 21, 2020
September 17, 2020
January 21, 2020
Amendments (1)
Dec 08, 2020
Agreed to in Senate
1
Sponsorship
Senate Amendment 2694
In the nature of a substitute.
Agreed To
Public Record
Record Updated
Jan 11, 2023 1:45:05 PM